跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,905 条关于
“Midas Private Equity”
全部
3,905
临床试验
1,158
药物
60
机构
261
资讯
2,426
去年
Mezzion Secures $20 Million to Advance Phase 3 Trial of Udenafil for Rare Congenital Heart Disease
去年
Private Equity Hospital Acquisitions Lead to Declining Patient Care Experience, JAMA Study Finds
去年
Study Reveals Higher Mortality and Complication Rates for Esophagectomy at Private Equity-Owned Hospitals
去年
Senate Investigation Reveals Concerning Impact of Private Equity Ownership on Healthcare Quality and Safety
11个月前
Private Equity Consortium Lowers Acceptance Threshold for Bavarian Nordic Takeover Amid Shareholder Opposition
去年
Verastem Oncology Refinances Debt and Advances Avutometinib/Defactinib Combination
去年
MAIA Biotechnology Secures $2.44 Million to Advance THIO-101 Trial in NSCLC
2年前
Lixte Biotechnology Faces Nasdaq Delisting Over Equity Shortfall, Plans Compliance Measures
去年
Theralase Closes Private Placement to Advance Bladder Cancer Clinical Study
去年
MAIA Biotechnology Secures $2.44 Million to Advance THIO-101 Trial in NSCLC
第 1 页,共 243 页
上一页
下一页